Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Express Scripts
Medtronic

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Fluphenazine hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for fluphenazine hydrochloride and what is the scope of patent protection?

Fluphenazine hydrochloride is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Pharm Assoc, Schering, Apothecon, Fresenius Kabi Usa, Lannett Co Inc, Mylan, Sandoz, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for fluphenazine hydrochloride. Eight suppliers are listed for this compound.

Recent Clinical Trials for fluphenazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Network for Observational Drug Effect Studies, CNODESN/A
Canadian Institutes of Health Research (CIHR)N/A
Drug Safety and Effectiveness Network, CanadaN/A

See all fluphenazine hydrochloride clinical trials

Pharmacology for fluphenazine hydrochloride
Drug ClassPhenothiazine
Synonyms for fluphenazine hydrochloride
1-(2-Hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine dihydrochloride
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-, dihydrochloride
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, dihydrochloride
1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-, dihydrochloride
10-(3-(4-(2-Hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine dihydrochloride
146-56-5
2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride
2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol dihydrochloride
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethan-1-ol dihydrochloride
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol dihydrochloride
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,dihydrochloride
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
36315-90-9
4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol dihydrochloride
4-[3-[2-(Trifluoromethyl)-10H-pheno-thiazin-10-yl]-1-piperazineethanol 2HCl
4-[3-[2-(Trifluoromethyl)-10H-pheno-thiazin-10-yl]-1-piperazineethanol dihydrochloride
4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride
A 4077
AB0019790
AC-12201
AC1L27DO
AC1Q3ALH
AKOS015960787
Anatensol
API0002739
BCP18079
C22H26F3N3OS
C22H27ClF3N3OS
Calmansial
CCG-212902
CCRIS 4032
CHEBI:5126
CHEMBL1448187
CS-4290
CTK8F9824
D00791
Dapotum
EINECS 205-674-1
EU-0100555
F 4765
Flufenazin
FLUFENAZINE HYDROCHLORIDE
Fluorophenazine dihydrochloride
Fluphenazine (dihydrochloride)
Fluphenazine chloride
Fluphenazine DiHCl
Fluphenazine dihydrochloride
Fluphenazine Dihydrochloride 1.0 mg/ml in Methanol (as free base)
Fluphenazine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Fluphenazine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
FLUPHENAZINE HCL
Fluphenazine hydrochloride (JAN/USP)
Fluphenazine hydrochloride [BAN:JAN]
Fluphenazine hydrochloride [USP:BAN:JAN]
Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Fluphenazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
FT-0668755
GP2994
HMS1568P22
HMS1921O14
HY-A0081
Liogen
LP00555
LS-112567
Lyorodin
MBHNWCYEGXQEIT-UHFFFAOYSA-N
MFCD00055212
Mirenil
Moditen
MolPort-000-917-736
NCGC00093941-01
NCGC00093941-02
NCGC00093941-03
NCGC00261240-01
NSC 179197
OMCA
Permitil
Permitil hydrochloride
Prestwick_225
Prolixin
Prolixin (TN)
s4569
S4569 Fluphenazine (dihydrochloride).cd
SCHEMBL41634
SPECTRUM1500994
Squibb 4918
SR-01000003048
SR-01000003048-2
SR-01000003048-9
Tensofin
Tox21_500555
Trancin
UNII-ZOU145W1XL
V0295
W-108125
Z2784093501
ZOU145W1XL

US Patents and Regulatory Information for fluphenazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089586-002 Oct 16, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089804-004 Aug 12, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Sandoz FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089586-004 Oct 16, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
Schering PERMITIL fluphenazine hydrochloride TABLET;ORAL 012034-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Baxter
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.